These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 8618579)

  • 1. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.
    Anzueto A; Baughman RP; Guntupalli KK; Weg JG; Wiedemann HP; Raventós AA; Lemaire F; Long W; Zaccardelli DS; Pattishall EN
    N Engl J Med; 1996 May; 334(22):1417-21. PubMed ID: 8618579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome.
    Weg JG; Balk RA; Tharratt RS; Jenkinson SG; Shah JB; Zaccardelli D; Horton J; Pattishall EN
    JAMA; 1994 Nov; 272(18):1433-8. PubMed ID: 7933425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.
    Spragg RG; Lewis JF; Walmrath HD; Johannigman J; Bellingan G; Laterre PF; Witte MC; Richards GA; Rippin G; Rathgeb F; Häfner D; Taut FJ; Seeger W
    N Engl J Med; 2004 Aug; 351(9):884-92. PubMed ID: 15329426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant therapy in respiratory distress syndrome--the first local experience.
    Lim NL; Nordin MM; Cheah IG
    Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolized surfactant in sepsis-induced adult respiratory distress syndrome.
    Doig C
    JAMA; 1995 Apr; 273(16):1259-60. PubMed ID: 7715036
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes of acute respiratory distress syndrome (ARDS) in elderly patients.
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2007 Aug; 63(2):344-50. PubMed ID: 17693834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome.
    Weg JG; Anzueto A; Balk RA; Wiedemann HP; Pattishall EN; Schork MA; Wagner LA
    N Engl J Med; 1998 Feb; 338(6):341-6. PubMed ID: 9449726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets.
    Sood SL; Balaraman V; Finn KC; Wilkerson SY; Mundie TG; Easa D
    Pediatr Pulmonol; 1996 Dec; 22(6):376-86. PubMed ID: 9016471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
    Smyth J; Allen A; MacMurray B; Peliowski A; Sankaran K; Volberg F; Shukla A; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S81-9. PubMed ID: 7745516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.
    Steinberg KP; Hudson LD; Goodman RB; Hough CL; Lanken PN; Hyzy R; Thompson BT; Ancukiewicz M;
    N Engl J Med; 2006 Apr; 354(16):1671-84. PubMed ID: 16625008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome.
    Ely EW; Wheeler AP; Thompson BT; Ancukiewicz M; Steinberg KP; Bernard GR
    Ann Intern Med; 2002 Jan; 136(1):25-36. PubMed ID: 11777361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A prospective randomized control clinical study of the effect of Xuebijing injection on prognosis of acute respiratory distress syndrome patients].
    Chen QH; Zheng RQ; Lin H; Wang HL; Lu NF; Shao J; Yu JQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jul; 21(7):405-8. PubMed ID: 19615131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
    da Costa DE; Pai MG; Al Khusaiby SM
    Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Xuebijing injection treatment on acute respiratory distress syndrome: a multicenter prospective randomized control clinical trial].
    LIU SQ; ZHENG RQ; LI MQ; YAN J; CHEN HY; MU XW; CHANG RH; YE ZL; LI XS; GAO YH; QIU XH; HUANG YZ; GUO FM; YANG Y; QIU HB
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(15):1017-22. PubMed ID: 22781640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
    Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
    Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
    Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
    J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose corticosteroids in patients with the adult respiratory distress syndrome.
    Bernard GR; Luce JM; Sprung CL; Rinaldo JE; Tate RM; Sibbald WJ; Kariman K; Higgins S; Bradley R; Metz CA
    N Engl J Med; 1987 Dec; 317(25):1565-70. PubMed ID: 3317054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.